Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain is a research paper published in British Journal of Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: NSF1456818
National Institutes of Health
Grant: MH116003
National Institutes of Health
Grant: NS104705
National Institutes of Health
Grant: NS118731
NIMH NIH HHS
Grant: R01 MH116003
NINDS NIH HHS
Grant: R21 NS132590
NINDS NIH HHS
Grant: R01 NS118731
NINDS NIH HHS
Grant: R21 NS104705
FWCI
1.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals